Saenger et al. reported that polyethylene glycol-modified IGF-1 treatment in a SOD1-G93A ALS mouse with a low transgene copy number significantly delayed symptom onset, increased forelimb grip strength, and improved rotarod performance [41]. The gene discussed is IGF1; the disease is amyotrophic lateral sclerosis.